University, Subject, Country, Region, World

GlaxoSmithKline Scientist and University Rankings 2022

Country

Total 389 scientist, 1 university

List without CERN, Statistical Data etc.

Sort by last 5 years H Index

				AD Scientific Index - Scientist Rankings - 2022				H INDEX			i10 INDEX			CITATION
University	Country	Region	World	Name	Country	University	Subject	Total	Last 5 year	Last 5 year/total	Total	Last 5 year	Last 5 year/total	Total	Last 5 year	Last 5 year/total
1	89	344	1040	Rino Rappuoli	United Kingdom	GlaxoSmithKline	GSK Vaccines Vaccines\|infectious diseases\|vaccinology\|global health\|	149	79	0.530	706	417	0.591	86418	24494	0.283
2	136	478	1541	Paul Peter Tak	United Kingdom	GlaxoSmithKline	Candel Therapeutics, GlaxoSmithKline, Kintai Therapeutics, Academic Medical Center, Amsterdam immunology\|oncology\|rheumatology\|internal medicine\|	135	78	0.578	561	433	0.772	79723	32704	0.410
3	455	1479	4908	Peter Howarth	United Kingdom	GlaxoSmithKline	SOUTHAMPTON and GSK	103	54	0.524	321	190	0.592	46001	12306	0.268
4	575	1863	6255	Derek O'Hagan	United Kingdom	GlaxoSmithKline	GSK Vaccines\|adjuvants\|RNA vaccines\|LNP\|	97	46	0.474	278	157	0.565	26912	7443	0.277
5	989	3225	10608	Caroline Savage	United Kingdom	GlaxoSmithKline	VP and Head of Experimental Medicine, GSK immunology\|renal medicine\|	84	37	0.440	108	106	0.981	26432	6840	0.259
6	1132	3731	12206	Mariagrazia Pizza	United Kingdom	GlaxoSmithKline	GSK Vaccines Vaccines\|pathogenesis\|	81	41	0.506	171	167	0.977	23624	6743	0.285
7	1146	3786	12370	Jaegil Kim	United Kingdom	GlaxoSmithKline	GSK Cancer Genomics\|	80	78	0.975	105	106	1.010	59015	51833	0.878
8	1315	4328	14090	Allan Saul	United Kingdom	GlaxoSmithKline	Director of GSK Vaccines Institute for Global Health Vaccines\|public health\|	78	37	0.474	126	122	0.968	20132	4864	0.242
9	1409	4601	14914	Toby Johnson ⁱ	United Kingdom	GlaxoSmithKline	GlaxoSmithKline	76	62	0.816	119	100	0.840	48455	21397	0.442
10	2546	8905	27775	Rab Prinjha	United Kingdom	GlaxoSmithKline	GlaxoSmithkline Epigenetics\|	63	51	0.810	113	113	1.000	17780	9905	0.557
11	2807	9858	30461	Jerry L Adams	United Kingdom	GlaxoSmithKline	Research Director for GlaxoSmithKline drug discovery\|	61	29	0.475	50	50	1.000	18097	2608	0.144
12	2858	10054	30986	Neil Barnes	United Kingdom	GlaxoSmithKline	Professor Respiratory disease\|	61	33	0.541	61	61	1.000	14043	4625	0.329
13	2925	10382	31875	David Tough	United Kingdom	GlaxoSmithKline	GSK Immunology\|Epigenetics\|	60	36	0.600	69	69	1.000	19577	4494	0.230
14	3205	11484	35127	Gerard Drewes	United Kingdom	GlaxoSmithKline	Cellzome/GlaxoSmithKline R&D Drug Discovery\|Chemical Biology\|Proteomics\|Kinases\|	58	44	0.759	80	79	0.988	27296	8880	0.325
15	3354	12095	37058	Sanjay Kumar	United Kingdom	GlaxoSmithKline	glaxosmithkline	57	30	0.526	99	95	0.960	21642	4650	0.215
16	3374	12137	37195	Marcus Bantscheff	United Kingdom	GlaxoSmithKline	Cellzome, a GSK company Proteomics\|Chemical Biologý\|	57	48	0.842	78	77	0.987	18041	10636	0.590
17	3564	12887	39312	Philippe Buchy	United Kingdom	GlaxoSmithKline	GSK Vaccines R&D virology - vaccinology\|	56	39	0.696	128	127	0.992	15553	9146	0.588
18	3736	13618	41360	Christine Power	United Kingdom	GlaxoSmithKline	GlaxoSmithKline	55	25	0.455	44	42	0.955	15873	2356	0.148
19	4087	15068	45587	Millard H Lambert	United Kingdom	GlaxoSmithKline	Computational Chemist, GlaxoSmithKline Drug Discovery\|Drug Design\|	53	33	0.623	49	49	1.000	23926	3973	0.166
20	4842	18291	54885	David J Payne	United Kingdom	GlaxoSmithKline	GlaxoSmithKline, Univeristy of Edinburgh, University Brunel	50	23	0.460	38	38	1.000	9591	2773	0.289
21	5138	19525	58175	Timothy M Clay	United Kingdom	GlaxoSmithKline	GSK Cancer\|infectious disease\|vaccines\|cell and gene therapy\|	49	27	0.551	52	52	1.000	8679	2550	0.294
22	5477	21224	62830	Roland S. Annan	United Kingdom	GlaxoSmithKline	Mass Spectrometry\|Proteomics\|Phosphorylation\|	47	22	0.468	39	39	1.000	14998	3279	0.219
23	5551	21480	63578	Amanda Leach	United Kingdom	GlaxoSmithKline	Vaccine Malaria\|	47	23	0.489	47	47	1.000	9957	2503	0.251
24	5788	22592	66683	John R White	United Kingdom	GlaxoSmithKline	GlaxoSmithKline Chemokines\|Cytokines\|Immunology\|receptors\|	46	16	0.348	22	23	1.045	11268	1089	0.097
25	6082	23947	70430	Colin Macphee	United Kingdom	GlaxoSmithKline	GSK Pharmacolgy\|	45	21	0.467	43	43	1.000	10883	1815	0.167
26	6473	25739	75234	Eduardo Ortega-Barria	United Kingdom	GlaxoSmithKline	VP & Head, Clinical R&D and Medical Affairs Latin America and the Caribbean Vaccines\|Infectious Disease\|Pediatrics\|Tropical Medicine & Parasitolgy\|	44	24	0.545	53	52	0.981	8357	2258	0.270
27	6672	26810	78078	Alistair Rust	United Kingdom	GlaxoSmithKline	Computational Biologist, GSK Bioinformatics\|Cancer Genetics\|Big Data\|HPC\|Drug Discovery\|	43	31	0.721	47	47	1.000	21258	6491	0.305
28	6731	27028	78798	Roger A Levy	United Kingdom	GlaxoSmithKline	GSK Lupus\|rheumatology\|pregnancy\|antiphospholipid syndrome\|Sjogren's syndrome\|	43	30	0.698	70	65	0.929	9993	4595	0.460
29	7379	30324	87757	George P Livi	United Kingdom	GlaxoSmithKline	GlaxoSmithKline Molecular Biology\|Genetics\|Genomics\|Transcriptomics\|Yeast\|	41	18	0.439	27	26	0.963	11653	1368	0.117
30	7410	30437	88085	Vinod Kumar	United Kingdom	GlaxoSmithKline	Sr. Investigator, GlaxoSmithKline Pharmaceuticals Bioinformatics\|Text mining\|Compuattional Biology\|Drug Repositioning\|	41	29	0.707	103	90	0.874	9536	4872	0.511
31	7518	30830	89226	Andrew Bate	United Kingdom	GlaxoSmithKline	GSK, LSHTM, NYU Pharmacovigilance\|Pharmacoepidemiology\|Data Mining\|Clinical Pharmacology\|Drug Safety\|	41	29	0.707	54	54	1.000	7188	3024	0.421
32	7519	30839	89250	Sylvie Bertholet	United Kingdom	GlaxoSmithKline	Director Preclinical Evidence Generation, Preclinical R&D, GSK Vaccines, Rockville MD immunology\|vaccine\|host-pathogen interaction\|	41	27	0.659	52	51	0.981	7168	2834	0.395
33	7759	32129	92595	Erding Hu	United Kingdom	GlaxoSmithKline	GlaxoSmithKline Pharmaceuticals Drug discovery\|Cell biology\|Renal and cardiovascular disease\|	40	27	0.675	37	37	1.000	19632	3248	0.165
34	7776	32214	92854	Frank Struyf	United Kingdom	GlaxoSmithKline	GlaxoSmithKline	40	35	0.875	58	57	0.983	12002	6851	0.571
35	8102	33798	97154	Iain A Gillespie	United Kingdom	GlaxoSmithKline	Real-World Evidence & Epidemiology, GSK Epidemiology\|	40	23	0.575	40	39	0.975	5023	1512	0.301
36	8156	34176	98092	Shanker Kalyana-Sundaram	United Kingdom	GlaxoSmithKline	GlaxoSmithKline, Collegeville Bioinformatics\|Cancer Biology\|Big Data\|Cloud Computing\|	39	31	0.795	42	42	1.000	20524	8311	0.405
37	8171	34224	98260	Kurt Auger	United Kingdom	GlaxoSmithKline	GlaxoSmithKline Cancer cell biology\|Tumor cell signaling\|Synthetic Lethality\|	39	23	0.590	31	31	1.000	13443	2163	0.161
38	8324	34899	100262	Javier Gamo	United Kingdom	GlaxoSmithKline	GlaxoSmithKline Infectious diseases. Parasitology. Drug Discovery.Molecular Biology. Biochemistry. Genetics. Malaria\|	39	32	0.821	61	61	1.000	6446	3764	0.584
39	8591	36360	104009	Erik Arner	United Kingdom	GlaxoSmithKline	GSK bioinformatics\|epigenomics\|transcriptomics\|adipogenesis\|obesity\|	38	31	0.816	52	51	0.981	14550	8432	0.580
40	9259	39636	113152	Nathalie Norais	United Kingdom	GlaxoSmithKline	GSK Vaccines Vaccines\|Structural Mass Spectrometry\|Proteomics\|	37	28	0.757	46	44	0.957	5423	1875	0.346
41	9609	41413	118048	Maciej Zamek-Gliszczynski	United Kingdom	GlaxoSmithKline	Senior Fellow and Director, Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Pharmacokinetics\|Clinical Pharmacology\|Drug Development\|	36	24	0.667	44	43	0.977	6556	2974	0.454
42	9643	41558	118523	Dennis A Holt	United Kingdom	GlaxoSmithKline	GlaxoSmithKline Drug Discovery\|	36	18	0.500	32	31	0.969	6054	1195	0.197
43	9652	41583	118599	Domenico Maione	United Kingdom	GlaxoSmithKline	GSK Vaccines Biologia\|Microbiologia\|Biochimica\|	36	23	0.639	44	44	1.000	5987	1948	0.325
44	9676	41687	118917	Pierre Wattiau	United Kingdom	GlaxoSmithKline	Sr Scientist, GSK Vaccines Molecular Microbiology\|	36	20	0.556	37	36	0.973	5746	1438	0.250
45	9732	41894	119480	Nicholas Galwey	United Kingdom	GlaxoSmithKline	GlaxoSmithKline biostatistics\|	36	22	0.611	38	38	1.000	5379	1786	0.332
46	9985	43491	123608	Roberto Adamo	United Kingdom	GlaxoSmithKline	GSK	36	27	0.750	52	49	0.942	3227	2094	0.649
47	9996	43550	123797	Dean E Mcnulty	United Kingdom	GlaxoSmithKline	GlaxoSmithKline	35	21	0.600	29	29	1.000	16223	2923	0.180
48	10014	43618	123987	Andreas Crameri	United Kingdom	GlaxoSmithKline	Associate GSK Fellow, GSK Stevenage BioTech\|Molecular Biology Protein evolution\|	35	27	0.771	41	41	1.000	11403	2987	0.262
49	10243	44642	126916	Alessandro Muzzi	United Kingdom	GlaxoSmithKline	GSK Systems Biology\|Transcriptomics\|Gene Expression\|Genomics\|Bioinformatics\|	35	24	0.686	38	38	1.000	4984	1877	0.377
50	10612	46628	132067	Michael T. Mccabe	United Kingdom	GlaxoSmithKline	Epigenetics\|Oncology\|	34	25	0.735	37	36	0.973	7630	4521	0.593
51	10750	47237	133868	María S. Martínez	United Kingdom	GlaxoSmithKline	Investigator, GSK DMPK\|	34	27	0.794	52	59	1.135	5191	2789	0.537
52	10970	48388	136987	Anthony M Lynch	United Kingdom	GlaxoSmithKline	GSK genetic toxicology\|photo-safety\|mutagens\|carcinogens\|non-clinical safety\|	34	18	0.529	28	28	1.000	3947	1023	0.259
53	11223	49819	140674	Sandra Nuti	United Kingdom	GlaxoSmithKline	Head of FACS Facility, Preclinical R&D, GSK Vaccines, Rockville, MD flow cytometry\|immunology\|vaccines\|	33	19	0.576	26	26	1.000	6394	1381	0.216
54	11292	50062	141375	Lisa Shewchuk	United Kingdom	GlaxoSmithKline	GlaxoSmithkline structure biology\|	33	19	0.576	31	31	1.000	5501	1476	0.268
55	11749	52719	148402	Margaret (Meg) Gelder Ehm	United Kingdom	GlaxoSmithKline	GlaxoSmithKline statistics\|genetics\|	32	18	0.563	43	30	0.698	11537	2421	0.210
56	12420	56261	158180	Robert T. Nolte	United Kingdom	GlaxoSmithKline	GlaxoSmithKline Protein Crystallography\|	31	24	0.774	31	31	1.000	8458	1705	0.202
57	12457	56400	158624	Mike Hann	United Kingdom	GlaxoSmithKline	GlaxoSmithKline Medicinal chemistry\|Fragments\|chemical biology\|drug discovery\|	31	22	0.710	30	30	1.000	6704	2290	0.342
58	12506	56520	158989	Sabyasachi Bhattacharya	United Kingdom	GlaxoSmithKline	Investigator, GlaxoSmithKline Onco immunology\|	31	22	0.710	39	447	11.462	5938	2180	0.367
59	12530	56616	159276	Diana L Cousminer	United Kingdom	GlaxoSmithKline	Natural Sciences / Molecular Biology & Genetics genetics\|	31	29	0.935	40	40	1.000	5546	3926	0.708
60	12593	56889	160021	Ganesh Sathe	United Kingdom	GlaxoSmithKline	GlaxoSmithKline DNA Sequencing\|	31	16	0.516	21	21	1.000	4885	1076	0.220
61	13128	59916	167989	Pichai Raman	United Kingdom	GlaxoSmithKline	Oncology, Data Strategy & Design Director at GSK Data Mining\|Cancer Biology\|Early Target Discovery\|	30	28	0.933	39	39	1.000	12846	9626	0.749
62	13143	59968	168158	Andrew W Nicholls	United Kingdom	GlaxoSmithKline	Head of Bioimaging, GlaxoSmithKline metabolomics\|toxicology\|imaging\|	30	16	0.533	25	23	0.920	9632	4766	0.495
63	13210	60194	168832	Robert Marquis	United Kingdom	GlaxoSmithKline	GSK	30	19	0.633	31	29	0.935	6279	3167	0.504
64	13218	60210	168910	Kendall Frazier	United Kingdom	GlaxoSmithKline	glaxosmithkline Toxicology\|Pathology\|	30	20	0.667	32	31	0.969	6114	2118	0.346
65	13492	61428	172383	Shari N Gordon	United Kingdom	GlaxoSmithKline	GlaxoSmithKline and the UNC HIV Cure Center HIV\|	30	18	0.600	28	28	1.000	3754	1129	0.301
66	13926	63964	178956	Philippe Sanseau	United Kingdom	GlaxoSmithKline	GSK	29	18	0.621	24	23	0.958	11043	4619	0.418
67	14029	64313	180073	Puneet Dhawan	United Kingdom	GlaxoSmithKline	GSK Genomics\|NGS\|Vitamin D\|	29	20	0.690	28	27	0.964	5285	2871	0.543
68	14086	64543	180855	Laure Rittié	United Kingdom	GlaxoSmithKline	GlaxoSmithKline Gene Therapy\|Immuno-Oncology\|Dermatology\|Tissue repair\|	29	22	0.759	37	36	0.973	4542	2376	0.523
69	14120	64688	181278	Sharon Sweitzer	United Kingdom	GlaxoSmithKline	GlaxoSmithKline	29	16	0.552	19	19	1.000	4251	1240	0.292
70	14154	64862	181800	Kevin J Duffy	United Kingdom	GlaxoSmithKline	GlaxoSmithKline	29	16	0.552	20	20	1.000	4007	1471	0.367
71	14399	66038	185062	Luis A. Vale-Silva	United Kingdom	GlaxoSmithKline	Cellzome, a GSK company Spatial Omics\|Multiomics\|Cancer\|Computer Vision\|Deep Learning\|	29	23	0.793	31	30	0.968	3125	1725	0.552
72	14687	68016	190408	Jimmy Zhenli Liu ⁱ	United Kingdom	GlaxoSmithKline	GSK Statistical genetics\|genetic epidemiology\|genetics\|bioinformatics\|	28	24	0.857	32	31	0.969	8010	5901	0.737
73	14720	68170	190958	Jing Chen	United Kingdom	GlaxoSmithKline	Cincinnati Children's Hospital Medical Center Bioinformatics\|Computational biology\|Drug Discovery\|	28	20	0.714	42	32	0.762	5775	3568	0.618
74	14820	68576	192140	Kristin (Koretke) Brown	United Kingdom	GlaxoSmithKline	Agenus computational biology/chemistry\|target tractability\|antibody design\|directed evolution\|protein engineering\|	28	19	0.679	36	25	0.694	4360	1237	0.284
75	14866	68751	192615	Ian Churcher	United Kingdom	GlaxoSmithKline	GSK drug discovery\|	28	18	0.643	28	26	0.929	4060	2563	0.631
76	15191	70563	197386	William Feeney	United Kingdom	GlaxoSmithKline	oncology\|immunology\|animal models\|	28	10	0.357	11	10	0.909	2872	392	0.136
77	15526	72742	203092	Laura A Johnson	United Kingdom	GlaxoSmithKline	GSK cancer\|immunotherapy\|cell therapy\|gene therapy\|GBM\|	27	25	0.926	31	31	1.000	7505	4553	0.607
78	15763	73719	206014	Esther Perez-Herrán	United Kingdom	GlaxoSmithKline	Investigator microbiology\|	27	21	0.778	32	50	1.563	3599	1389	0.386
79	15964	74750	208833	James Yates	United Kingdom	GlaxoSmithKline	Scientific Director, GSK Drug discovery\|pharmacology\|mathematical modelling\|	27	21	0.778	42	40	0.952	2933	2097	0.715
80	16034	75155	209892	Neil D Pearson	United Kingdom	GlaxoSmithKline	GlaxoSmithKline Medicinal Chemistry and Infectious Disease\|	27	11	0.407	53	12	0.226	2775	920	0.332
81	16215	76498	213311	Richard Lonsdale	United Kingdom	GlaxoSmithKline	GlaxoSmithKline Computational Chemistry\|	27	25	0.926	35	35	1.000	2363	1562	0.661
82	16272	76942	214493	Robert J Watson	United Kingdom	GlaxoSmithKline	GSK medicinal chemistry\|	27	19	0.704	25	23	0.920	2211	928	0.420
83	16367	77814	216699	Pankaj Agarwal	United Kingdom	GlaxoSmithKline	Chief Computational Biologist, BioInfi Computational Biology\|Bioinformatics\|Drug Discovery\|Target Identification\|Drug Repositioning\|	26	18	0.692	30	30	1.000	11788	2829	0.240
84	16388	77880	216968	Adrián Cortés	United Kingdom	GlaxoSmithKline	GSK statistical genetics\|genetics of immune-mediated diseases\|	26	25	0.962	29	28	0.966	7598	6474	0.852
85	16416	77993	217380	Euan Stronach	United Kingdom	GlaxoSmithKline	GSK Oncology\|Functional Genomics\|	26	22	0.846	36	31	0.861	5692	4009	0.704
86	16530	78411	218742	John D Lich	United Kingdom	GlaxoSmithKline	Pharma Immuno-inflammation\|	26	19	0.731	22	21	0.955	4033	1889	0.468
87	16590	78685	219496	Robert B Henderson	United Kingdom	GlaxoSmithKline	Glaxo Smith Kline	26	23	0.885	34	31	0.912	3615	1690	0.467
88	16601	78754	219691	Augustin Amour	United Kingdom	GlaxoSmithKline	GSK PI3K\|Kinases\|Proteases\|metalloproteinases\|	26	15	0.577	21	21	1.000	3536	860	0.243
89	16825	79822	222699	Leonardo Giovannoni	United Kingdom	GlaxoSmithKline	GSK Vaccines clinical research\|	26	19	0.731	23	23	1.000	2833	1010	0.357
90	17021	81027	225879	Christian Fufezan	United Kingdom	GlaxoSmithKline	Group Leader Computational Mass Spectrometry Cellzome - GSK Data engineering\|Computational Biology\|ROS\|Proteostasis\|	26	21	0.808	37	32	0.865	2418	1322	0.547
91	17178	82238	229081	Gossett Campbell	United Kingdom	GlaxoSmithKline	GlaxoSmithKline Inc	26	12	0.462	16	16	1.000	2075	359	0.173
92	17179	82244	229093	Gerben Bouma	United Kingdom	GlaxoSmithKline	GlaxoSmithKline R&D Immunology\|	26	16	0.615	24	23	0.958	2074	780	0.376
93	17272	83188	231601	Gregg Fine	United Kingdom	GlaxoSmithKline	Cell & Gene Therapy - Clinical Development, GSK Immunotherapy\|Cell therapy\|Urothelial carcinoma\|Renal cell carcinoma\|PD-L1\|	25	17	0.680	26	25	0.962	16088	12835	0.798
94	17409	83797	233705	Richard M. Dunham	United Kingdom	GlaxoSmithKline	Director, HIV Cure- ViiV Healthcare; Adj Asst Prof, UNC HIV Cure\|HIV Immunopathogenesis\|Mucosal Immunology\|Drug Discovery\|	25	16	0.640	25	24	0.960	3834	1505	0.393
95	17535	84361	235300	James Butler	United Kingdom	GlaxoSmithKline	GlaxoSmithKline, GSK biopharmaceutics\|dissolution\|drug delivery\|	25	23	0.920	34	30	0.882	3159	1768	0.560
96	17614	84743	236387	Stephen Castellino	United Kingdom	GlaxoSmithKline	GlaxoSmithKline, North Dakota Sate, University of Utah chemistry\|drug metabolism\|spectrscopy\|NMR\|MALDI\|	25	17	0.680	23	23	1.000	2895	1009	0.349
97	17625	84830	236604	Lisa Marcaurelle	United Kingdom	GlaxoSmithKline	GlaxoSmithKline	25	13	0.520	20	19	0.950	2855	645	0.226
98	18056	87712	244159	Jeremy Thomas O'Brien	United Kingdom	GlaxoSmithKline	Development Scientist at GSK Chemistry\|Mass Spectrometry\|Infrared Spectroscopy\|	25	17	0.680	24	24	1.000	2008	697	0.347
99	18102	88028	244995	David A Hall	United Kingdom	GlaxoSmithKline	FLI DPU, GlaxoSmithKline Pharmacology\|Receptor Theory\|GPCRs\|Allosteric modulation\|	25	13	0.520	16	15	0.938	1928	470	0.244
100	18499	90348	251462	Roberto Rosini	United Kingdom	GlaxoSmithKline	GSK Vaccines Vaccines\|Molecular biology\|Genomics\|	24	21	0.875	28	26	0.929	3052	1206	0.395